Depending on how one views it, the stock price performance for the year has been a mixed bag, resulting in either an optimistic or pessimistic outlook. The metric has seen a significant loss of -24.18% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -7.22%. Over the past 30 days, the price of TEVA has fallen by 0.48%. And in the last five days, it has surged by 13.91%.
Teva- Pharmaceutical Industries Ltd. ADR experienced a rather steady stock market performance. The highest value in the past year was recorded at $22.80 on 12/27/24 and the lowest value was $12.51 on 04/19/24.
52-week price history of TEVA Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Teva- Pharmaceutical Industries Ltd. ADR’s current trading price is -26.71% away from its 52-week high, while its distance from the 52-week low is 33.57%. The stock’s price range during this period has varied between$12.51 and $22.80. The Teva- Pharmaceutical Industries Ltd. ADR’s shares, which operate in the Healthcare, saw a trading volume of around 9.68 million for the day, a figure considerably lower than their average daily volume of 13.28 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Teva- Pharmaceutical Industries Ltd. ADR (TEVA) has experienced a quarterly decline of -4.24% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 19.15B and boasts a workforce of 36167 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 18.31, with a change in price of -1.24. Similarly, Teva- Pharmaceutical Industries Ltd. ADR recorded 11,009,860 in trading volume during the last 100 days, posting a change of -6.91%.
TEVA’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for TEVA stands at 3.38. Similarly, the long-term debt-to-equity ratio is also 3.03.
TEVA Stock Stochastic Average
As of today, Teva- Pharmaceutical Industries Ltd. ADR’s raw stochastic average for the last 50 days stands at 28.47%. This is a decline compared to the raw stochastic average of the previous 20 days, which was noted at 71.23%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 64.62% and 62.21%, respectively.
